Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Study of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis

NCT01114880 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01114880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01114880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Study of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2010
Completion date
February 28, 2011
Enrollment
344 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis